United States · FDA National Drug Code directory
Rizatriptan Benzoate ODT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72189-341_2c4c5f32-a754-7f96-e063-6394a90ad938
- Product NDC
- 72189-341
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Rizatriptan Benzoate ODT
- Labeler
- Direct Rx
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220328
- Source listing expiry
- 20261231
Source-listed ingredients
- RIZATRIPTAN BENZOATE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 9 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (72189-341-09) · 72189-341-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →